Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Down 90.5% in April

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw a significant decline in short interest in April. As of April 30th, there was short interest totaling 21,619 shares, a decline of 90.5% from the April 15th total of 226,933 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 54,689 shares, the days-to-cover ratio is currently 0.4 days.

Nihon Kohden Stock Up 1.6%

NHNKY stock traded up $0.15 during trading on Monday, hitting $9.27. The company had a trading volume of 10,663 shares, compared to its average volume of 40,974. The firm has a 50-day moving average price of $9.58 and a 200-day moving average price of $10.60. Nihon Kohden has a 12 month low of $8.93 and a 12 month high of $14.21. The stock has a market cap of $1.58 billion, a price-to-earnings ratio of 18.18 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY) last released its earnings results on Thursday, February 5th. The company reported $0.16 EPS for the quarter. The company had revenue of $362.86 million during the quarter. Nihon Kohden had a return on equity of 7.25% and a net margin of 5.32%. Equities analysts expect that Nihon Kohden will post 0.48 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 19th. Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Nihon Kohden has an average rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.